Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 91.25 INR
Change Today 0.00 / 0.00%
Volume 0.0
LPH On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:26 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

lincoln pharmaceuticals ltd (LPH) Snapshot

Open
83.00
Previous Close
81.90
Day High
95.50
Day Low
82.10
52 Week High
01/14/15 - 118.40
52 Week Low
07/31/14 - 33.60
Market Cap
1.5B
Average Volume 10 Days
205.0K
EPS TTM
6.53
Shares Outstanding
16.3M
EX-Date
09/25/14
P/E TM
14.0x
Dividend
0.60
Dividend Yield
0.66%
Current Stock Chart for LINCOLN PHARMACEUTICALS LTD (LPH)

Related News

No related news articles were found.

lincoln pharmaceuticals ltd (LPH) Related Businessweek News

No Related Businessweek News Found

lincoln pharmaceuticals ltd (LPH) Details

Lincoln Pharmaceuticals Limited manufactures, markets, and exports pharmaceutical products in India and internationally. The company’s product categories include antimalarial, antibiotics, anti-bactarials, analgesics, anti-inflammatory, anti-pyretics, anti-hypertensives, anti-fungal, antacids, anti-ulcers, anthelmintics, anti-cold, anti-allergic, anti-asthmatics, anti-emetics, gastrointestinal-agents, anti-diarrhoeals, anti-spasmodics, and pro-biotics, as well as cardiac and diuretic products. It also provides creams, ointments, anti-infectives, vitamins, minerals, and iron-preparations. In addition, the company trades finished goods, chemicals products, and bulk drugs. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

Founded in 1979

lincoln pharmaceuticals ltd (LPH) Top Compensated Officers

Joint Managing Director and Director
Total Annual Compensation: 1.2M
Managing Director, Whole Time Director, Membe...
Total Annual Compensation: 1.2M
Whole-Time Director and Member of Shareholder...
Total Annual Compensation: 1.2M
Compliance Officer and Member of Shareholders...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

lincoln pharmaceuticals ltd (LPH) Key Developments

Lincoln Pharmaceuticals Ltd., Board Meeting, Apr 16, 2015

Lincoln Pharmaceuticals Ltd., Board Meeting, Apr 16, 2015.

Lincoln Pharmaceuticals Ltd. Reports Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Lincoln Pharmaceuticals Ltd. reported unaudited standalone and consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the group reported net sales of INR 645.158 million, profit from operations before other income, finance coasts and exceptional items of INR 52.228 million, profit from ordinary activities before tax of INR 35.150 million and net profit after taxes, minority interest and share of profit of associates of INR 25.897 million or INR 1.59 per basic and diluted share (after extraordinary items not annualized) compared to net sales of INR 519.940 million, profit from operations before other income, finance coasts and exceptional items of INR 60.278 million, profit from ordinary activities before tax of INR 40.396 million and net profit after taxes, minority interest and share of profit of associates of INR 33.009 million or INR 2.02 per basic and diluted share (after extraordinary items not annualized) reported in the same period last year. For the nine months, the group reported net sales of INR 1,873.762 million, profit from operations before other income, finance coasts and exceptional items of INR 219.448 million, profit from ordinary activities before tax of INR 164.607 million and net profit after taxes, minority interest and share of profit of associates of INR 128.109 million or INR 7.85 per basic and diluted share (after extraordinary items not annualized) compared to net sales of INR 1,442.973 million, profit from operations before other income, finance coasts and exceptional items of INR 146.349 million, profit from ordinary activities before tax of INR 107.120 million and net profit after taxes, minority interest and share of profit of associates of INR 99.574 million or INR 6.10 per basic and diluted share (after extraordinary items not annualized) reported in the same period last year. For the quarter, the parent company reported net sales of INR 567.047 million, profit from operations before other income, finance coasts and exceptional items of INR 48.944 million, profit from ordinary activities before tax of INR 36.897 million and net profit after taxes, minority interest and share of profit of associates of INR 28.042 million or INR 1.72 per basic and diluted share (after extraordinary items not annualized) compared to net sales of INR 511.669 million, profit from operations before other income, finance coasts and exceptional items of INR 64.231 million, profit from ordinary activities before tax of INR 47.008 million and net profit after taxes, minority interest and share of profit of associates of INR 38.300 million or INR 2.35 per basic and diluted share (after extraordinary items not annualized) reported in the same period last year. For the nine months, the parent company reported net sales of INR 1,609.705 million, profit from operations before other income, finance coasts and exceptional items of INR 203.554 million, profit from ordinary activities before tax of INR 162.830 million and net profit after taxes, minority interest and share of profit of associates of INR 128.601 million or INR 7.88 per basic and diluted share (after extraordinary items not annualized) compared to net sales of INR 1,429.207 million, profit from operations before other income, finance coasts and exceptional items of INR 146.928 million, profit from ordinary activities before tax of INR 115.738 million and net profit after taxes, minority interest and share of profit of associates of INR 108.488 million or INR 6.65 per basic and diluted share (after extraordinary items not annualized) reported in the same period last year.

Lincoln Pharmaceuticals Ltd. to Report Q3, 2015 Results on Feb 13, 2015

Lincoln Pharmaceuticals Ltd. announced that they will report Q3, 2015 results on Feb 13, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LPH:IN 91.25 INR 0.00

LPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LPH.
View Industry Companies
 

Industry Analysis

LPH

Industry Average

Valuation LPH Industry Range
Price/Earnings 11.2x
Price/Sales 0.6x
Price/Book 1.4x
Price/Cash Flow 8.4x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LINCOLN PHARMACEUTICALS LTD, please visit www.lincolnpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.